Literature DB >> 26681074

Can bioactive compounds of Crocus sativus L. influence the metabolic activity of selected CYP enzymes in the rat?

G Dovrtělová1, K Nosková, J Juřica, M Turjap, O Zendulka.   

Abstract

Safranal and crocin are biologically active compounds isolated from Crocus sativus L., commonly known as saffron. Clinical trials confirm that saffron has antidepressant effect, thus being a potential valuable alternative in the treatment of depression. The aim of the present study was to determine, whether systemic administration of safranal and crocin can influence the metabolic activity of CYP3A, CYP2C11, CYP2B, and CYP2A in rat liver microsomes (RLM). The experiments were carried out on male Wistar albino rats intragastrically administered with safranal (4, 20, and 100 mg/kg/day) or with intraperitoneal injections of crocin (4, 20, and 100 mg/kg/day). Our results demonstrate the ability of safranal and crocin to increase the total protein content and to change the metabolic activity of several CYP enzymes assessed as CYP specific hydroxylations of testosterone in RLM. Crocin significantly decreased the metabolic activity of all selected CYP enzymes, while safranal significantly increased the metabolic activity of CYP2B, CYP2C11 and CYP3A enzymes. Therefore, both substances could increase the risk of interactions with co-administered substances metabolized by cytochrome P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26681074     DOI: 10.33549/physiolres.933203

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  2 in total

1.  Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A.

Authors:  Kristýna Nosková; Gabriela Dovrtělová; Ondřej Zendulka; Markéta Strakošová; Ondřej Peš; Jan Juřica
Journal:  Pharmacol Rep       Date:  2020-01-13       Impact factor: 3.024

Review 2.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.